To read this content please select one of the options below:

Developing the role of the drug and therapeutics committees: perceptions of chairs

Ingeborg K. Björkman (Department of Public Health and Caring Sciences, University of Uppsala, Uppsala, Sweden and Apoteket AB, Stockholm, Sweden)
Ingrid K. Schmidt (The National Board of Health and Welfare, Stockholm, Sweden)
Inger Holmström (Department of Public Health and Caring Sciences, University of Uppsala, Uppsala, Sweden)
Cecilia B. Bernsten (Department of Public Health and Caring Sciences, University of Uppsala, Uppsala, Sweden)

International Journal of Health Care Quality Assurance

ISSN: 0952-6862

Article publication date: 27 March 2007

414

Abstract

Purpose

According to Swedish law, every county is required to have a local drug and therapeutics committee (DTC) to contribute to safe and cost‐effective drug use. The law presents merely a framework and gives no detailed instructions addressing, for example, organisation and methods. The aim of this study is to explore the variation of conceptions of the role of the DTCs among committee Chairs and to compare the results with an earlier study.

Design/methodology/approach

Data were collected by questionnaires and telephone interviews with committee chairs, which were analysed using a phenomenographic approach.

Findings

Four conceptions were identified, namely: traditional, patient‐aware, influential, holistic and cooperative, which all involved prescribers. In one conception the DTC acted as an expert to decision‐makers. One conception included the notion that cooperation across the bureaucratic borders was important. Patients were involved in two conceptions. Comparison with the earlier study showed a trend toward higher patient awareness and a higher agreement on DTC goals with an increased focus on quality issues.

Originality/value

This study demonstrates an alternative research method bringing in new perspectives when exploring activities within healthcare. Patient involvement in the work of the DTCs is increasing, but should be further explored and developed.

Keywords

Citation

Björkman, I.K., Schmidt, I.K., Holmström, I. and Bernsten, C.B. (2007), "Developing the role of the drug and therapeutics committees: perceptions of chairs", International Journal of Health Care Quality Assurance, Vol. 20 No. 2, pp. 161-178. https://doi.org/10.1108/09526860710731843

Publisher

:

Emerald Group Publishing Limited

Copyright © 2007, Emerald Group Publishing Limited

Related articles